Adriana is a Colombian born neuroscientist particularly interested in meaningful problems of complexity and scale.
She is currently working on optimizing the process of technology transfer & commercialization in emerging markets with a particular focus in Latin America. The current puzzle is how to get LATAM scientists the best licensing agreements for their inventions.
While working in academia at the Montreal Neurological Institute, Adriana contributed to the discovery of an important mechanism underlying the development of epileptic seizures.
After six years of working in academia, Adriana transitioned to the pharmaceutical industry. While working at Vertex Pharmaceuticals, Adriana co-developed the preclinical phase of Kalydeco, the only treatment available up to date for patients suffering from Cystic Fibrosis. Today, Kalydeco is a nichebuster drug.
Adriana has a passion for both continuous learning and asking tough questions. She is an out the box thinker and an independent scholar. Adriana currently consults for both government and the private sector.
In addition to science, Adriana is also passionate about helping other entrepreneurs grow. She is a contributor for The Next Woman, Women 2.0, Eureka Startups, YoSoyPyme-BBVA & Ellas 2.0 among some other venues.
She also mentors in several global accelerators including Startup Weeks, Wayra LATAM, GoCode Colorado & The Next Woman.
In her free time, Adriana is a Firefighter/EMT in Colorado.
She is available for Technology Commercialization, Go to Market Strategy, Financial Analysis & Venture Capital related questions in English, Spanish or French.